NEPTUNIUM, RADIOACTIVE:  Nuclear Waste Reprocessing Emissions

Other Chemical/Physical Properties :
DECAY PATHWAY: Neptunium-237, half-life 2,144,000 years, decays via alpha emission, 4.959 MeV, to protactinium-233, half-life 26.967 days. Protactinium-233 decays via beta emission, 0.571 MeV, to uranium-233, half-life 159,200 years.
[Korea Atomic Energy Research Institute. Nuclear Data Evaluation Lab. 2000. Nuclide Table. Available from the database query page at http://atom.kaeri.re.kr/ton/ as of Feb 9, 2006. ]**PEER REVIEWED**


Other Chemical/Physical Properties :
DECAY PATHWAY: Neptunium-239, half-life 2.3565 days, decays via beta(-) emission, 0.722 MeV, to plutonium-239, half-life 24,110 years. Plutonium-239 decays via alpha emission, 5.245 MeV, to uranium-235, half-life 703,800,000 years.
[Korea Atomic Energy Research Institute. Nuclear Data Evaluation Lab. 2000. Nuclide Table. Available from the database query page at http://atom.kaeri.re.kr/ton/ as of Feb 9, 2006. ]**PEER REVIEWED**


Radiation Limits & Potential :
DECAY PATHWAY: Neptunium-237, half-life 2,144,000 years, decays via alpha emission, 4.959 MeV, to protactinium-233, half-life 26.967 days. Protactinium-233 decays via beta emission, 0.571 MeV, to uranium-233, half-life 159,200 years.
[Korea Atomic Energy Research Institute. Nuclear Data Evaluation Lab. 2000. Nuclide Table. Available from the database query page at http://atom.kaeri.re.kr/ton/ as of Feb 9, 2006. ]**PEER REVIEWED**


Radiation Limits & Potential :
DECAY PATHWAY: Neptunium-239, half-life 2.3565 days, decays via beta(-) emission, 0.722 MeV, to plutonium-239, half-life 24,110 years. Plutonium-239 decays via alpha emission, 5.245 MeV, to uranium-235, half-life 703,800,000 years.
[Korea Atomic Energy Research Institute. Nuclear Data Evaluation Lab. 2000. Nuclide Table. Available from the database query page at http://atom.kaeri.re.kr/ton/ as of Feb 9, 2006. ]**PEER REVIEWED**


Environmental Fate/Exposure Summary :
Neptunium was the first synthetic transuranium element of the actinide series discovered. Neptunium-239 (half-life = 2.4 days) was first produced in 1940 at Berkeley, CA by the bombardment of uranium-238 with cyclotron-produced neutrons. Seventeen isotopes of neptunium are known and all are radioactive. Neptunium-237 is obtained in gram quantities as the by-product from nuclear reactors in the production of plutonium. The longest lived isotope is Np-237; it is an alpha-emitter with a half-life of 2.14 million years. Neptunium is a by-product of plutonium production activities. Neptunium is present in spent nuclear fuel, high-level radioactive wastes resulting from the processing of spent nuclear fuel, and radioactive wastes associated with operations of reactors and fuel reprocessing plants. A small amount of neptunium would have been generated by atmospheric nuclear weapon testing, which ceased worldwide by 1980. The amount of neptunium in soil from past nuclear testing is on the order of 0.0001 pCi/g. Releases of neptunium from weapons production facilities have cause localized contamination. There are no major commercial uses of neptunium. Trace quantities of neptunium are found in nature associated with uranium ores. Neptunium compounds are ionic and would not be volatile and would exist solely in the particulate phase in the ambient atmosphere. Particulate-phase neptunium compounds will be removed from the atmosphere by wet or dry deposition. In soil, neptunium is generally more mobile than other transuranic elements such as plutonium, americium, and curium, moving with percolating water to lower soil layers. Neptunium compounds bind to soil particles, and bind more tightly with clay soils as compared with sandy soils. Neptunium is readily taken up by plants, with plant concentrations similar to soil concentrations. Neptunium compounds are ionic and would not volatilize from moist or dry soil surfaces. Neptunium has 4 valence states in water: Np3+; Np4+; NpO+; and (NpO)2+. Neptunium forms tri- and tetrahalide compounds such as NpF3, NpF4, NpCl4, NpBr3, NpI3, and oxides of various compositions such as Np3O8 and NpO2. Since neptunium has only been produced in limited quantities and it has few uses outside of research activities, exposure to neptunium compounds would be limited to individuals involved in scientific research using neptunium or at plutonium production or nuclear waste facilities. (SRC)
**PEER REVIEWED**


Artificial Pollution Sources :
Neptunium was the first synthetic transuranium element of the actinide series discovered(1,2). Neptunium-239 (half-life = 2.4 days) was first produced in 1940 at Berkeley, CA by the bombardment of uranium-238 with cyclotron-produced neutrons(1,2). Seventeen isotopes of neptunium are known and all are radioactive(1). Neptunium-237 is obtained in gram quantities as the by-product from nuclear reactors in the production of plutonium(2). The longest lived isotope is neptunium-237; it is an alpha-emitter with a half-life of 2.14 million years(3). Neptunium is a by-product of plutonium production activities(1). Neptunium is present in spent nuclear fuel, high-level radioactive wastes resulting from the processing of spent nuclear fuel, and radioactive wastes associated with operations of reactors and fuel reprocessing plants(1). A small amount of neptunium would have been generated by atmospheric nuclear weapon testing, which ceased worldwide by 1980(1). The amount of neptunium in soil from past nuclear testing is on the order of 0.0001 pCi/g(1). Releases of neptunium from weapons production facilities have caused localized contamination(1). There are no major commercial uses of neptunium(1). Neptunium forms tri- and tetrahalide compounds such as NpF3, NpF4, NpCl4, NpBr3, NpI3, and oxides of various compositions such as Np3O8 and NpO2(2).
[(1) Argonne National Laboratory/EVS. Human Health Fact Sheet, August 2005. Neptunium. Available at: http://www.ead.anl.gov/pub/doc/Neptunium.pdf as of Jan 24, 2006. (2) Lide DR; CRC Handbook of Chemistry and Physics 86th ed. 2005-2006. CRC Press, Talyor & Francis, Boca Raton, FL p. 4-24 (3) O'Neil MJ, ed; The Merck Index. 13th ed Whitehouse Station, NJ: Merck and Co, Inc, p. 1160 (2001) ]**PEER REVIEWED**


Sediment/Soil Concentrations :
SEDIMENT: The British Nuclear Fuels Ltd nuclear fuel reprocessing plants at Sellafield in Cumbria, UK discharge low level radioactive waste into the Irish Sea(1). Neptunium-237 concentrations in sediment cores samples collected in October 1994 from 9 sites around the intertidal area of the Irish Sea, UK ranged from 13.1 to 412 mBq/kg(1)
[(1) Kuwabara J, et al; J Radioanal Nucl Chem 240: 593-601 (1999) ]**PEER REVIEWED**

MORE ABOUT HEALTH EFFECTS

Evidence for Carcinogenicity:
Evaluation. There is inadequate evidence in humans for the carcinogenicity of neutrons. There is sufficient evidence in experimental animals for the carcinogenicity of neutrons. Overall evaluation. Neutrons are carcinogenic to humans (Group 1). In making the overall evaluation, the Working Group took into consideration the following: When interacting with biological material, fission neutrons generate protons, and the higher-energy neutrons used in therapy generate protons and alpha particles. Alpha Particle-emitting radionuclides (e.g. radon) are known to be human carcinogens. The linear energy transfer of protons overlaps with that of the lower-energy electrons produced by gamma-radiation. Neutron interactions also generate gamma-radiation, which is a human carcinogen. Gross chromosomal aberrations (including rings, dicentrics and acentric fragments) and numerical chromosomal aberrations are induced in the lymphocytes of people exposed to neutrons. The spectrum of DNA damage induced by neutrons is similar to that induced by X-radiation but contains relatively more of the serious (i.e. less readily repairable) types. Every relevant biological effect of gamma- or X-radiation that has been examined has been found to be induced by neutrons. Neutrons are several times more effective than X- and gamma-radiation in inducing neoplastic cell transformation, mutation in vitro, germ-cell mutation in vivo, chromosomal aberrations in vivo and in vitro and cancer in experimental animals.
[IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work)., p. V75 431 (2000)]**PEER REVIEWED**

Internalized radionuclides that emit alpha-particles are carcinogenic to humans (Group 1). In making this overall evaluation, the Working Group took into consideration the following: (1) Alpha-Particles emitted by radionuclides, irrespective of their source, produce the same pattern of secondary ionizations and the same pattern of localized damage to biological molecules, including DNA. These effects, observed in vitro, include DNA double-strand breaks, chromosomal aberrations, gene mutations and cell transformation. (2) All radionuclides that emit alpha-particles and that have been adequately studied, including radon-222 and its decay products, have been shown to cause cancer in humans and in experimental animals. (3) Alpha-Particles emitted by radionuclides, irrespective of their source, have been shown to cause chromosomal aberrations in circulating lymphocytes and gene mutations in humans in vivo. (4) The evidence from studies in humans and experimental animals suggests that similar doses to the same tissues, for example lung cells or bone surfaces, from alpha particles emitted during the decay of different radionuclides produce the same types of non-neoplastic effects and cancers.
[IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work)., p. V78 479 (2001)]**PEER REVIEWED**


Human Toxicity Excerpts:
/OTHER TOXICITY INFORMATION/ In the nuclear fuel cycle the transuranic radionuclides plutonium-239, americium-241 and neptunium-237 would probably present the most serious hazard to human health if released into the environment. ... The principal late effects of all three radionuclides are the induction of cancers of bone, lung or liver. For the latter tumors the induction risk per unit radiation dose appears similar for the three radionuclides. But in bone there are indications that, due to microscopic differences in the distribution of the alpha-particle radiation dose, the efficiency of bone cancer induction may increase in the order americium-241 less than plutonium-239 less than neptunium-237. No case of human cancer induced by these radionuclides is known. /Plutonium-239, americium-241 and neptunium-237/
[Taylor DM; Sci Total Environ 83(3): 217-25 (1989) ]**PEER REVIEWED**

/OTHER TOXICITY INFORMATION/ LIFETIME CANCER MORTALITY RISK. Risks are for lifetime cancer mortality per unit intake (pCi) averaged over all ages and both genders. /Neptunium isotopes/
ISOTOPE Inhalation (pCi-1) Ingestion (pCi-1)
Neptunium-235 1.0x10-12 2.8x10-13
Neptunium-236 2.6x10-9 1.5x10-11
Neptunium-237 1.5x10-8 5.8x10-11

[Argonne National Laboratory; EVS Human Health Fact Sheet, Neptunium. August 2005. Available at http://www.ead.anl.gov/pub/doc/neptunium.pdf as of October 10, 2006 ]**PEER REVIEWED**


Probable Routes of Human Exposure:
Since neptunium has only been produced in limited quantities(1) and it has few uses outside of research activities(2), exposure to neptunium compounds would be limited to individuals involved in scientific research using neptunium or at plutonium production or nuclear waste facilities(SRC).
[(1) Lide DR; CRC Handbook of Chemistry and Physics 86th ed. 2005-2006. CRC Press, Talyor & Francis, Boca Raton, FL p. 4-24 (2005) (2) Argonne National Laboratory/EVS. Human Health Fact Sheet, August 2005. Neptunium. Available at: http://www.ead.anl.gov/pub/doc/neptunium.pdf as of Jan 24, 2006. ]**PEER REVIEWED**


Evidence for Carcinogenicity:
Evaluation. There is inadequate evidence in humans for the carcinogenicity of neutrons. There is sufficient evidence in experimental animals for the carcinogenicity of neutrons. Overall evaluation. Neutrons are carcinogenic to humans (Group 1). In making the overall evaluation, the Working Group took into consideration the following: When interacting with biological material, fission neutrons generate protons, and the higher-energy neutrons used in therapy generate protons and alpha particles. Alpha Particle-emitting radionuclides (e.g. radon) are known to be human carcinogens. The linear energy transfer of protons overlaps with that of the lower-energy electrons produced by gamma-radiation. Neutron interactions also generate gamma-radiation, which is a human carcinogen. Gross chromosomal aberrations (including rings, dicentrics and acentric fragments) and numerical chromosomal aberrations are induced in the lymphocytes of people exposed to neutrons. The spectrum of DNA damage induced by neutrons is similar to that induced by X-radiation but contains relatively more of the serious (i.e. less readily repairable) types. Every relevant biological effect of gamma- or X-radiation that has been examined has been found to be induced by neutrons. Neutrons are several times more effective than X- and gamma-radiation in inducing neoplastic cell transformation, mutation in vitro, germ-cell mutation in vivo, chromosomal aberrations in vivo and in vitro and cancer in experimental animals.
[IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work)., p. V75 431 (2000)]**PEER REVIEWED**

Internalized radionuclides that emit alpha-particles are carcinogenic to humans (Group 1). In making this overall evaluation, the Working Group took into consideration the following: (1) Alpha-Particles emitted by radionuclides, irrespective of their source, produce the same pattern of secondary ionizations and the same pattern of localized damage to biological molecules, including DNA. These effects, observed in vitro, include DNA double-strand breaks, chromosomal aberrations, gene mutations and cell transformation. (2) All radionuclides that emit alpha-particles and that have been adequately studied, including radon-222 and its decay products, have been shown to cause cancer in humans and in experimental animals. (3) Alpha-Particles emitted by radionuclides, irrespective of their source, have been shown to cause chromosomal aberrations in circulating lymphocytes and gene mutations in humans in vivo. (4) The evidence from studies in humans and experimental animals suggests that similar doses to the same tissues, for example lung cells or bone surfaces, from alpha particles emitted during the decay of different radionuclides produce the same types of non-neoplastic effects and cancers.
[IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work)., p. V78 479 (2001)]**PEER REVIEWED**


Probable Routes of Human Exposure:
Since neptunium has only been produced in limited quantities(1) and it has few uses outside of research activities(2), exposure to neptunium compounds would be limited to individuals involved in scientific research using neptunium or at plutonium production or nuclear waste facilities(SRC).
[(1) Lide DR; CRC Handbook of Chemistry and Physics 86th ed. 2005-2006. CRC Press, Talyor & Francis, Boca Raton, FL p. 4-24 (2005) (2) Argonne National Laboratory/EVS. Human Health Fact Sheet, August 2005. Neptunium. Available at: http://www.ead.anl.gov/pub/doc/neptunium.pdf as of Jan 24, 2006. ]**PEER REVIEWED**

All of the above is directly from
http://toxnet.nlm.nih.gov/

www.frankmckinnon.com